LSD
California Assembly Approves Psychedelics Legalization Bill
California is reaching the final stages of psychedelic legalization, as the California State Assembly passes a bill permitting the possession of certain…
California is reaching the final stages of psychedelic legalization, as the California State Assembly has passed a bill permitting the possession of certain psychedelics.
State Sen. Scott Wiener (D) has been working for years to get versions of this bill passed, and his Senate Bill 58 has now passed the Assembly in a 42-11 vote on Wednesday.
The legislation would legalize the possession and cultivation of psilocybin, psilocin, dimethyltryptamine (DMT) and mescaline (excluding peyote). The bill allows for the following possession amounts (but excludes synthetic psychedelics such as LSD and MDMA):
- Mescaline: 4 grams
- DMT: One gram
- Psilocybin: One gram, or up to one ounce of “a plant or fungi containing psilocybin”
- Psilocyn: One gram, or up to one ounce of “a plant or fungi containing psilocyn.”
The bill also proposes the establishment of “community-based healing” models to promote the therapeutic use of psychedelics in group settings.
BREAKING: The Assembly just passed our psychedelics decriminalization bill (SB 58).
SB 58 allows personal possession/use of small amounts of plant/mushroom psychedelics & creates a path for facilitated group use.
It’s supported by veterans, 1st responders, health professionals.
— Senator Scott Wiener (@Scott_Wiener) September 6, 2023
As reported in Marijuana Moment, members of the Assembly adopted a number of amendments including removing ibogaine from the list of legalized substances, lowering possession limits, and pushing back the effective date for legalization to 2025.
The bill now returns to the Senate for final approval of the amendments. Considering a previous version of the bill has already passed the Senate, we might soon see a final bill heading to the Governor’s desk for signing into law.
The post California Assembly Approves Psychedelics Legalization Bill appeared first on Microdose.
lsd dmt dimethyltryptamine peyote mescaline ibogaine-
Law & Regulation1 week ago
FDA to weigh safety, impact of MDMA therapy for PTSD at June meeting
-
Psychedelics1 week ago
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University’s Institute for Psychedelic Research
-
Ketamine1 week ago
Clinical-Stage BioTech Drug Stocks Portfolio UP 7% In w/e May 3rd
-
Psychedelics1 week ago
Optimi Health Provides Corporate Update
-
Law & Regulation1 week ago
Horizons talk shifts from investors to insurance
-
Law & Regulation1 week ago
DEA psychedelics ban hearing halted by lawsuit
-
Law & Regulation6 days ago
Relmada loses another $21.8M, makes progress with clinical trials
-
Psychedelics5 days ago
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001